A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)
Clinical trial NCT03059953 · COMPLETED
Trial details
- NCT number
- NCT03059953
- Sponsor
- Genesis Pharma S.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-07
- Primary completion
- 2018-04-06
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.